CTHRC1 and COVID-19: In COVID-19 fatalities, lung analyses have revealed inflammation-associated AT2 cell states that hinder proper regeneration, coupled with pathogenic fibroblasts expressing CTHRC1, possibly driving rapid pulmonary fibrosis progression [110].